STORM Therapeutics

Cambridge, United Kingdom · Founded 2015 · Privately Held (backing)

Operator of a biotechnology and drug discovery company intended to develop small molecule therapies for RNA modification enzymes for use in the treatment of cancer and other immune diseases. STORM Therapeutics is based in Cambridge, United Kingdom and was founded in 2015. Its last reported valuation was $90.3 million in Dec 2022. It has raised $172 million.

Last reported valuation

$90.3M

Oct 2026

Priced at

—

Total raised

$172.2M

Last round

—

How much has STORM Therapeutics raised?

$172.2Macross 0 recorded rounds

Free account

More of STORM Therapeutics with a free account

·The complete investor list: 12 names
·Watch STORM Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

STORM Therapeutics investors

12 investors are on record for STORM Therapeutics, including Innovate UK, Cambridge Enterprise Ventures, M Ventures and UTokyo Innovation Platform Company.

For fundraisers

Raising for a company like STORM Therapeutics?

12 investors have backed STORM Therapeutics.

See all 12 investors →

Frequently asked about STORM Therapeutics

How much has STORM Therapeutics raised?: STORM Therapeutics has raised $172.2M in total across 0 recorded funding rounds.